IGC PHARMA, INC. Other Significant Noncash Transaction, Value of Consideration Given
IGC PHARMA, INC. (IGC) reported Other Significant Noncash Transaction, Value of Consideration Given of $1.64 million for the 12-month period ending 2025-03-31, per its 10-K filed 2025-06-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1 · last filed 2025-06-27
- IGC PHARMA, INC. other significant noncash transaction, value of consideration given for the quarter ending 2025-03-31 was $390.00K, a 14.71% increase year-over-year.
- IGC PHARMA, INC. other significant noncash transaction, value of consideration given for the quarter ending 2024-12-31 was $446.00K, a 15.21% decline year-over-year.
- IGC PHARMA, INC. other significant noncash transaction, value of consideration given for the quarter ending 2024-09-30 was $371.00K, a 32.55% decline year-over-year.
- IGC PHARMA, INC. other significant noncash transaction, value of consideration given for the quarter ending 2024-06-30 was $433.00K, a 21.29% increase year-over-year.
- IGC PHARMA, INC. other significant noncash transaction, value of consideration given for fiscal 2025 was $1.64M, a 7.50% decline from fiscal 2024.
- IGC PHARMA, INC. other significant noncash transaction, value of consideration given for fiscal 2024 was $1.77M, a 37.64% decline from fiscal 2023.
- IGC PHARMA, INC. other significant noncash transaction, value of consideration given for fiscal 2023 was $2.84M, a 29.40% increase from fiscal 2022.
- IGC PHARMA, INC. other significant noncash transaction, value of consideration given for fiscal 2022 was $2.20M, a 171.91% increase from fiscal 2021.
| Period end | Other Significant Noncash Transaction, Value of Consideration Given 3 month | Other Significant Noncash Transaction, Value of Consideration Given 3 month as first filed | Other Significant Noncash Transaction, Value of Consideration Given 6 month | Other Significant Noncash Transaction, Value of Consideration Given 6 month as first filed | Other Significant Noncash Transaction, Value of Consideration Given 9 month | Other Significant Noncash Transaction, Value of Consideration Given 9 month as first filed | Other Significant Noncash Transaction, Value of Consideration Given 12 month | Other Significant Noncash Transaction, Value of Consideration Given 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | $390.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-27 | $836.00K derived: sum of 2 quarters · filed 2025-06-27 | $1.21M derived: sum of 3 quarters · filed 2025-06-27 | $1.64M 10-K · filed 2025-06-27 | ||||
| 2024-12-31 | $446.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-14 | $817.00K derived: sum of 2 quarters · filed 2025-02-14 | $1.25M 10-Q · filed 2025-02-14 | $1.59M derived: sum of 4 quarters · filed 2025-06-27 | ||||
| 2024-09-30 | $371.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-12 | $804.00K 10-Q · filed 2024-11-12 | $1.14M derived: sum of 3 quarters · filed 2025-06-27 | $1.67M derived: sum of 4 quarters · filed 2025-06-27 | ||||
| 2024-06-30 | $433.00K 10-Q · filed 2024-08-07 | $773.00K derived: sum of 2 quarters · filed 2025-06-27 | $1.30M derived: sum of 3 quarters · filed 2025-06-27 | $1.85M derived: sum of 4 quarters · filed 2025-06-27 | ||||
| 2024-03-31 | $340.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-27 | $866.00K derived: sum of 2 quarters · filed 2025-06-27 | $1.42M derived: sum of 3 quarters · filed 2025-06-27 | $1.77M 10-K · filed 2025-06-27 | ||||
| 2023-12-31 | $526.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-14 | $1.08M derived: sum of 2 quarters · filed 2025-02-14 | $1.43M 10-Q · filed 2025-02-14 | $2.02M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-09-30 | $550.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-12 | $907.00K 10-Q · filed 2024-11-12 | $1.49M derived: sum of 3 quarters · filed 2024-11-12 | $1.97M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $357.00K 10-Q · filed 2024-08-07 | $940.00K derived: sum of 2 quarters · filed 2024-08-07 | $1.42M derived: sum of 3 quarters · filed 2024-08-07 | $2.05M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | $583.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-24 | $1.07M derived: sum of 2 quarters · filed 2024-06-24 | $1.69M derived: sum of 3 quarters · filed 2024-06-24 | $2.84M 10-K · filed 2024-06-24 | $2.84M 10-K · filed 2023-07-07 | |||
| 2022-12-31 | $484.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-14 | $1.11M derived: sum of 2 quarters · filed 2024-02-14 | $2.26M 10-Q · filed 2024-02-14 | $3.38M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-09-30 | $624.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-09 | $1.78M 10-Q · filed 2023-11-09 | $2.90M derived: sum of 3 quarters · filed 2023-11-09 | $3.42M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $1.15M 10-Q · filed 2023-08-10 | $2.28M derived: sum of 2 quarters · filed 2023-08-10 | $2.80M derived: sum of 3 quarters · filed 2023-08-10 | $3.22M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-07 | $1.65M derived: sum of 2 quarters · filed 2023-07-07 | $2.07M derived: sum of 3 quarters · filed 2023-07-07 | $2.20M 10-K · filed 2023-07-07 | ||||
| 2021-12-31 | $523.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-14 | $947.00K derived: sum of 2 quarters · filed 2023-02-14 | $1.07M 10-Q · filed 2023-02-14 | $1.31M derived: sum of 4 quarters · filed 2023-02-14 | ||||
| 2021-09-30 | $424.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-01 | $549.00K 10-Q · filed 2022-11-01 | $784.00K derived: sum of 3 quarters · filed 2022-11-01 | $941.00K derived: sum of 4 quarters · filed 2022-11-01 | ||||
| 2021-06-30 | $125.00K 10-Q · filed 2022-08-05 | $360.00K derived: sum of 2 quarters · filed 2022-08-05 | $517.00K derived: sum of 3 quarters · filed 2022-08-05 | $767.00K derived: sum of 4 quarters · filed 2022-08-05 | ||||
| 2021-03-31 | $235.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-23 | $392.00K derived: sum of 2 quarters · filed 2022-06-23 | $642.00K derived: sum of 3 quarters · filed 2022-06-23 | $808.00K 10-K · filed 2022-06-23 | $150.00K 10-K · filed 2021-06-14 | |||
| 2020-12-31 | $157.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-10 | $407.00K derived: sum of 2 quarters · filed 2022-02-10 | $573.00K 10-Q · filed 2022-02-10 | $50.00K 10-Q · filed 2021-02-16 | $573.00K derived: sum of 4 quarters · filed 2022-02-10 | |||
| 2020-09-30 | $250.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-10-29 | $416.00K 10-Q · filed 2021-10-29 | $51.00K 10-Q · filed 2020-11-20 | $416.00K derived: sum of 3 quarters · filed 2021-10-29 | $416.00K derived: sum of 4 quarters · filed 2021-10-29 | |||
| 2020-06-30 | $166.00K 10-Q · filed 2021-08-11 | $166.00K derived: sum of 2 quarters · filed 2021-08-11 | $166.00K derived: sum of 3 quarters · filed 2021-08-11 | $166.00K derived: sum of 4 quarters · filed 2021-08-11 | ||||
| 2020-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-14 | $0.00 derived: sum of 2 quarters · filed 2021-06-14 | $0.00 derived: sum of 3 quarters · filed 2021-06-14 | $0.00 10-K · filed 2021-06-14 | ||||
| 2019-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-16 | $0.00 derived: sum of 2 quarters · filed 2021-02-16 | $0.00 10-Q · filed 2021-02-16 | $0.00 derived: sum of 4 quarters · filed 2021-02-16 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-20 | $0.00 10-Q · filed 2020-11-20 | $0.00 derived: sum of 3 quarters · filed 2020-11-20 | $0.00 derived: sum of 4 quarters · filed 2020-11-20 | ||||
| 2019-06-30 | $0.00 10-Q · filed 2019-08-09 | $0.00 derived: sum of 2 quarters · filed 2020-07-13 | $0.00 derived: sum of 3 quarters · filed 2020-07-13 | $0.00 derived: sum of 4 quarters · filed 2020-07-13 | ||||
| 2019-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-13 | $0.00 derived: sum of 2 quarters · filed 2020-07-13 | $0.00 derived: sum of 3 quarters · filed 2020-07-13 | $18.00K 10-K · filed 2020-07-13 | ||||
| 2018-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | $0.00 derived: sum of 2 quarters · filed 2020-02-10 | $18.00K 10-Q · filed 2020-02-10 | $94.00K derived: sum of 4 quarters · filed 2020-02-10 | ||||
| 2018-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-06 | $18.00K 10-Q · filed 2019-11-06 | $94.00K derived: sum of 3 quarters · filed 2019-11-06 | $141.00K derived: sum of 4 quarters · filed 2019-11-06 | ||||
| 2018-06-30 | $18.00K 10-Q · filed 2019-08-09 | $18.30K 10-Q · filed 2018-08-03 | $94.00K derived: sum of 2 quarters · filed 2019-08-09 | $141.00K derived: sum of 3 quarters · filed 2019-08-09 | $172.40K derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2018-03-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-14 | $123.00K derived: sum of 2 quarters · filed 2019-06-14 | $154.40K derived: sum of 3 quarters · filed 2019-06-14 | $191.00K 10-K · filed 2019-06-14 | $191.10K 10-K · filed 2018-06-21 | |||
| 2017-12-31 | $47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-12 | $78.40K derived: sum of 2 quarters · filed 2019-02-12 | $115.00K 10-Q · filed 2019-02-12 | $115.50K 10-Q · filed 2018-02-20 | $140.80K derived: sum of 4 quarters · filed 2019-02-12 | |||
| 2017-09-30 | $31.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-10-16 | $68.00K 10-Q · filed 2018-10-16 | $67.50K 10-Q · filed 2017-11-17 | $93.80K derived: sum of 3 quarters · filed 2018-10-16 | $126.50K derived: sum of 4 quarters · filed 2018-10-16 | |||
| 2017-06-30 | $36.60K 10-Q · filed 2018-08-03 | $62.40K derived: sum of 2 quarters · filed 2018-08-03 | $95.10K derived: sum of 3 quarters · filed 2018-08-03 | $135.18K derived: sum of 4 quarters · filed 2018-08-03 | ||||
| 2017-03-31 | $25.80K derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-21 | $58.50K derived: sum of 2 quarters · filed 2018-06-21 | $98.58K derived: sum of 3 quarters · filed 2018-06-21 | $129.82K 10-K · filed 2018-06-21 | ||||
| 2016-12-31 | $32.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-20 | $72.78K derived: sum of 2 quarters · filed 2018-02-20 | $104.02K 10-Q · filed 2018-02-20 | $104.00K 10-Q · filed 2017-02-21 | $123.26K derived: sum of 4 quarters · filed 2018-02-20 | |||
| 2016-09-30 | $40.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-17 | $71.31K 10-Q · filed 2017-11-17 | $90.56K derived: sum of 3 quarters · filed 2017-11-17 | $103.78K derived: sum of 4 quarters · filed 2017-11-17 | ||||
| 2016-06-30 | $31.24K 10-Q · filed 2017-08-18 | $50.48K derived: sum of 2 quarters · filed 2017-08-18 | $63.71K derived: sum of 3 quarters · filed 2017-08-18 | $84.38K derived: sum of 4 quarters · filed 2017-08-18 | ||||
| 2016-03-31 | $19.24K derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-14 | $32.47K derived: sum of 2 quarters · filed 2017-07-14 | $53.14K derived: sum of 3 quarters · filed 2017-07-14 | $94.24K 10-K · filed 2017-07-14 | ||||
| 2015-12-31 | $13.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-21 | $33.90K derived: sum of 2 quarters · filed 2017-02-21 | $75.00K 10-Q · filed 2017-02-21 | $74.93K 10-Q · filed 2016-02-16 | $104.13K derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-09-30 | $20.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-21 | $61.78K 10-Q · filed 2016-11-21 | $90.90K derived: sum of 3 quarters · filed 2016-11-21 | $146.10K derived: sum of 4 quarters · filed 2016-11-21 | ||||
| 2015-06-30 | $41.10K 10-Q · filed 2016-08-16 | $70.23K derived: sum of 2 quarters · filed 2016-08-16 | $125.43K derived: sum of 3 quarters · filed 2016-08-16 | $189.05K derived: sum of 4 quarters · filed 2016-08-16 | ||||
| 2015-03-31 | $29.13K derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-14 | $84.33K derived: sum of 2 quarters · filed 2016-07-14 | $147.94K derived: sum of 3 quarters · filed 2016-07-14 | $204.03K 10-K · filed 2016-07-14 | ||||
| 2014-12-31 | $55.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-16 | $118.82K derived: sum of 2 quarters · filed 2016-02-16 | $174.90K 10-Q · filed 2016-02-16 | $225.69K derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-09-30 | $63.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-13 | $119.70K 10-Q · filed 2015-11-13 | $170.49K derived: sum of 3 quarters · filed 2015-11-13 | $218.37K derived: sum of 4 quarters · filed 2015-11-13 | ||||
| 2014-06-30 | $56.09K 10-Q · filed 2015-08-14 | $106.88K derived: sum of 2 quarters · filed 2015-08-14 | $154.75K derived: sum of 3 quarters · filed 2015-08-14 | $220.25K derived: sum of 4 quarters · filed 2015-08-14 | ||||
| 2014-03-31 | $50.79K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-14 | $98.67K derived: sum of 2 quarters · filed 2015-07-14 | $164.16K derived: sum of 3 quarters · filed 2015-07-14 | $270.52K 10-K · filed 2015-07-14 | ||||
| 2013-12-31 | $47.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-12 | $113.37K derived: sum of 2 quarters · filed 2015-02-12 | $219.74K 10-Q · filed 2015-02-12 | $721.03K derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-09-30 | $65.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-13 | $171.85K 10-Q · filed 2014-11-13 | $673.15K derived: sum of 3 quarters · filed 2014-11-13 | $673.15K derived: sum of 4 quarters · filed 2014-11-13 | ||||
| 2013-06-30 | $106.36K 10-Q · filed 2014-08-14 | $607.66K derived: sum of 2 quarters · filed 2014-08-14 | $607.66K derived: sum of 3 quarters · filed 2014-08-14 | |||||
| 2013-03-31 | $501.30K derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-15 | $501.30K derived: sum of 2 quarters · filed 2014-07-15 | $501.30K 10-K · filed 2014-07-15 | |||||
| 2012-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-14 | $0.00 10-Q · filed 2014-02-14 | ||||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-08 | |||||||
| 2012-03-31 | $2.54M 10-K · filed 2014-07-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |